Oncolytic Vaccinia Virus Disrupts Tumor-Associated Vasculature in Humans
2013 · Cancer Research · 250 citations
https://doi.org/10.1158/0008-5472.can-12-2687
T
Tae-Ho Hwang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
104
Papers
4.6K
Citations
23
h-index
43
i10-index
Tae-Ho Hwang is an academic researcher from University of California, Davis. The author has contributed to research in topics: Virus-based gene therapy research & Viral Infectious Diseases and Gene Expression in Insects & Cancer Research and Treatments. The author has an h-index of 23, co-authored 89 publications.
ORCID: 0000-0001-7469-6010Papers by this author
worksA Mechanistic Proof-of-concept Clinical Trial With JX-594, a Targeted Multi-mechanistic Oncolytic Poxvirus, in Patients With Metastatic Melanoma
2011 · Molecular Therapy · 157 citations
https://doi.org/10.1038/mt.2011.132
Driver drowsiness detection using the in-ear EEG
2016 · 51 citations
https://doi.org/10.1109/embc.2016.7591763
Immunotherapy for Peritoneal Carcinomatosis: Challenges and Prospective Outcomes
2023 · Cancers · 30 citations
https://doi.org/10.3390/cancers15082383
Rhamnogalacturonan II is a Toll-like receptor 4 agonist that inhibits tumor growth by activating dendritic cell-mediated CD8+ T cells
2013 · Experimental & Molecular Medicine · 29 citations
https://doi.org/10.1038/emm.2013.14
10-Phenyltriazoyl Artemisinin is a Novel P-glycoprotein Inhibitor that Suppresses the Overexpression and Function of P-glycoprotein
2019 · Current Pharmaceutical Design · 8 citations
https://doi.org/10.2174/1381612825666190222155700
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat